NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) at present introduced the Firm will launch fiscal third quarter 2021 monetary outcomes on Tuesday, June 15, 2021, earlier than market open. The Firm will host a corresponding convention name and dwell webcast at 8:30 a.m. (EDT) / 1:30 p.m. (BST) to debate the outcomes and supply a company replace.
Convention Name Particulars:
US/Canada Participant Toll-Free Dial-In Quantity: (833) 614-1551
US/Canada Participant Worldwide Dial-In Quantity: (914) 987-7290
United Kingdom Worldwide Dial-In Quantity: 0800 9174 860
United Kingdom Native Dial-In Quantity: 0203 1070 289
Webcast Registration hyperlink: https://edge.media-server.com/mmc/p/saaze8yw
The Audit Committee of the Firm’s Board of Administrators accepted the dismissal of Deloitte & Touche LLP efficient Might 12, 2021. Ernst & Younger LLP has been appointed because the Firm’s successor auditor for U.S. reporting, efficient Might 12, 2021, and for the fiscal 12 months ended June 30, 2021. PKF Littlejohn LLP stays the Firm’s U.Ok. statutory auditors.
There have been no disagreements with Deloitte on any matter of accounting ideas or practices, monetary assertion disclosure or auditing scope or procedures.
For additional info, please contact:
UK Investor Contact:
|Walbrook PR Restricted||Tel: 020 7933 8780 or email@example.com|
|Paul McManus / Lianne Cawthorne||Mob: 07980 541 893 / 07584 391 303|
US Investor Contact:
Renalytix is a developer of synthetic intelligence-enabled medical in vitro diagnostic options for kidney illness, one of the widespread and expensive continual medical circumstances globally. Renalytix’s merchandise are being designed to make vital enhancements in kidney illness prognosis, transplant administration, medical care, affected person stratification for drug medical trials, and drug goal discovery. For extra info, go to www.renalytix.com.
Ahead Wanting Statements
This press launch accommodates forward-looking statements which are based mostly on administration’s beliefs and assumptions and on info presently accessible to administration. All statements contained on this launch apart from statements of historic truth are forward-looking statements, together with statements concerning our capability to develop, commercialize and obtain market acceptance of our present and deliberate services, our analysis and growth efforts, and different issues concerning our enterprise methods, use of capital, outcomes of operations and monetary place, and plans and aims for future operations.
In some circumstances, you may establish forward-looking statements by the phrases “might,” “will,” “may,” “would,” “ought to,” “anticipate,” “intend,” “plan,” “anticipate,” “consider,” “estimate,” “predict,” “venture,” “potential,” “proceed,” “ongoing” or the adverse of those phrases or different comparable terminology, though not all forward-looking statements comprise these phrases. These statements contain dangers, uncertainties and different elements that will trigger precise outcomes, ranges of exercise, efficiency, or achievements to be materially completely different from the data expressed or implied by these forward-looking statements. These dangers, uncertainties and different elements are described beneath “Danger Elements,” “Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operations” and elsewhere within the paperwork we file with the Securities and Trade Fee infrequently. We warning you that forward-looking statements are based mostly on a mix of details and elements presently recognized by us and our projections of the long run, about which we can’t be sure. In consequence, the forward-looking statements might not show to be correct. The forward-looking statements on this press launch signify our views as of the date hereof. We undertake no obligation to replace any forward-looking statements for any motive, besides as required by legislation.